$60.0 Million
Gamida Cell Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$132.0 Million
Akebia Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$120.0 Million
Aeglea BioTherapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.3 Million
Sutro Biopharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.1 Million
Crinetics Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$55.0 Million
Zynex, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$97.8 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
Matinas BioPharma Holdings, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$65.9 Million
OrthoPediatrics Corp.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$86.2 Million
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to CMFO

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.